Kent Meningitis Outbreak: Cases Rise to 20, Vaccination Efforts Underway

Health officials are investigating a growing outbreak of invasive meningococcal disease in Kent, England, with the number of reported cases rising to 20 as of March 18, 2026. Nine cases have been laboratory confirmed, with 11 more under investigation. Tragically, two deaths have been linked to the outbreak, and concerns are mounting as cases continue to emerge.

What is Meningococcal Disease?

Meningococcal disease is a serious bacterial infection that can cause meningitis (inflammation of the membranes surrounding the brain and spinal cord) and septicaemia (blood poisoning). It can develop rapidly and is potentially fatal. The current outbreak appears to involve invasive meningococcal disease caused by meningococcal bacteria as confirmed by the UK Health Security Agency (UKHSA).

Outbreak Details and Affected Groups

The majority of those affected are young adults, with cases linked to social gatherings and university settings. Six of the confirmed cases are Group B meningococcal disease. A baby with confirmed Meningococcal group B infection is also under investigation, though currently not linked to the outbreak according to the UKHSA. Cases have been reported in Canterbury, Faversham, and have extended to individuals presenting in London hospitals with connections to Kent. One case has also been identified in France, linked to a University of Kent attendee as reported by the Evening Standard.

Symptoms of Meningitis

Early symptoms of meningitis can include:

• Sudden onset of fever
• Stiff neck
• A rash that does not fade when a glass is rolled over it
• Severe headache
• Aversion to bright lights
• Vomiting and diarrhoea
• Seizures
• Joint and muscle pain
• Confusion
• Extreme sleepiness

It’s important to note that not all symptoms may be present as highlighted by The Guardian. If you suspect meningitis, it is crucial to seek immediate medical attention.

Public Health Response

Health officials are taking several steps to control the outbreak:

• Antibiotics: Over 2,500 doses of antibiotics have been administered to students, close contacts, and individuals who attended Club Chemistry in Canterbury between March 5th and 7th. GPs are now advised to prescribe antibiotics to anyone who visited the club during those dates and to University of Kent students who request preventative treatment .
• Vaccination Program: A targeted vaccination program is being launched, starting with students residing in Canterbury Campus Halls of Residence at the University of Kent. Around 5,000 students are expected to be vaccinated .
• National Oversight: The NHS has escalated oversight of the situation to a national level due to the unprecedented nature and rapid growth of the outbreak.
• Genome Sequencing: Laboratory scientists are conducting whole genome sequencing of the MenB strain to determine if it is a mutant strain and to assess its susceptibility to available vaccines.

Seeking Medical Attention

The UKHSA and NHS urge anyone who believes they or someone they care for may have meningitis, septicaemia, or sepsis to immediately call 999 or visit their nearest A&E department .

Key Takeaways

• An outbreak of invasive meningococcal disease is ongoing in Kent, England.
• 20 cases have been reported, with 9 confirmed and 11 under investigation.
• Two deaths have been linked to the outbreak.
• Young adults are primarily affected.
• Antibiotics and a targeted vaccination program are underway.
• Immediate medical attention is crucial if meningitis is suspected.